2009 Contributions Financial Statement
In 2009, the Johnson & Johnson Contributions Program continued to have an impact on worldwide health care issues.
In all areas of philanthropy, Johnson & Johnson emphasized initiatives supporting mothers, children, families and communities. The Company’s efforts focused on saving and improving lives, building health care capacity, and preventing diseases and reducing stigma. Beyond the Company’s global approach to giving, Johnson & Johnson companies supported communities based on local needs. During the year, Johnson & Johnson partnered with hundreds of local, regional and global organizations on 650 philanthropic programs around the world, contributing $588.1 million in cash and product.
The Company contributed $126.6 million in cash to organizations in the U.S. and abroad for Corporate and operating companies’ programs and projects in 2009. This included $10.7 million allocated through the Company’s U.S. Matching Gifts program. In 2009, Johnson & Johnson double matched contributions made by employees, and matched one-for-one contributions made by retirees up to $10,000 to qualified non-profit 501(c)(3) organizations in the U.S.*
Total cash and non-cash giving in 2009 was $588.1 million.
The Company contributed $126.6 million in cash to organizations in the U.S. and abroad for Corporate and operating companies’ programs and projects in 2009.
Johnson & Johnson companies also made $461.5 million in non-cash contributions in 2009. Product donations are reported at fair market value, which is consistent with the reporting methods of non-profit organizations. Of this total, $338.9 million of selected pharmaceutical products was contributed to needy patients in the U.S. during 2009. Over the past three years, our companies provided 2,755,204 units of medicine to 465,714 U.S. patients. The balance of non-cash contributions went to private voluntary organizations that assist medically underserved people in developing countries and provide emergency disaster relief.
The Company manages its Contributions Program within guidelines approved by the Johnson & Johnson Executive Committee. In 2009, total giving of $588.1 million represented an increase of about 15 percent above 2008 giving of $510.3 million, consistent with our continuing commitment to our philanthropic and patient assistance programs. Our Contributions budget is established well before the start of each fiscal year; our giving as a percent of year-end pretax income thus varies from year to year, as fluctuations in year-end pretax income become apparent. For 2009, our giving represented 3.7 percent of annual worldwide pretax income.
- * U.S. giving was done through the Johnson & Johnson Family of Companies Contribution Fund. Cash giving was distributed to more than 50 countries.
